Table 7 Kinetic release model data of the optimized formulation (B5) and marketed formulation
From: In-situ gel bases ocular delivery system of Ganciclovir, in-vivo and in-vitro investigation
Formulation name | Zero-order | First order | Higuchi model | Korsmeyer- Peppas model | ||||
|---|---|---|---|---|---|---|---|---|
R2 | K0 | R2 | K1 | R2 | KH | R2 | KKP | |
Optimized formulation (B5) | 0.9163 | 10.736 | 0.9405 | 0.07 | 0.9612 | 27.96 | 0.9519 | 0.84 |
Marketed formulation | 0.9949 | 16.65 | 0.8092 | 0.26 | 0.9351 | 41.48 | 0.9976 | 0.94 |